2019
DOI: 10.1016/j.cbi.2019.108825
|View full text |Cite
|
Sign up to set email alerts
|

Reviewing the mechanisms of natural product-drug interactions involving efflux transporters and metabolic enzymes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
11
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 20 publications
(11 citation statements)
references
References 235 publications
0
11
0
Order By: Relevance
“…The findings obtained with the extracts must be interpreted carefully if they are to be used for the benefit of patients. There are other factors such as pharmacokinetics and bioavailability [ 56 ], synergy or antagonism [ 57 , 58 ], and the adverse effects that the consumption of natural products can have that have not been developed correctly [ 59 ] and that can affect the patient, reducing their quality of life and the effect of allopathic therapy of choice.…”
Section: Discussionmentioning
confidence: 99%
“…The findings obtained with the extracts must be interpreted carefully if they are to be used for the benefit of patients. There are other factors such as pharmacokinetics and bioavailability [ 56 ], synergy or antagonism [ 57 , 58 ], and the adverse effects that the consumption of natural products can have that have not been developed correctly [ 59 ] and that can affect the patient, reducing their quality of life and the effect of allopathic therapy of choice.…”
Section: Discussionmentioning
confidence: 99%
“…Due to excessive drug usage, healthy or malignant cells may change their sensitivity towards exogenous substances by an increased expression or higher activity of transport pumps from ATP-binding cassette (ABC) superfamily, especially P-glycoprotein (P-gp). This situation can be overcome by competitive, non-competitive or allosteric P-gp inhibition or via affecting P-gp expression [20]. Silybin seems to be a prospective compound in this regard, as pre-incubation of P-gp-positive small-cell lung cancer (VPA17) cells at 30 µM for 5 days led to decreased IC 50 (concentration halving the viability) of etoposide [21].…”
Section: Introductionmentioning
confidence: 99%
“…Recently, we have demonstrated that paeonol can also protect against testicular ischemia-reperfusion injury [ 19 ]. On the other hand, the expression and/or activity of P-gp can be modulated by numerous natural products [ 20 ]; meanwhile, P-gp accepts paeonol as a substrate [ 21 ]. To the best of our knowledge, previous studies neither evaluated the protective effect of paeonol against MTX-induced testicular injury nor described the role of P-gp in paeonol protection against any testicular injury model.…”
Section: Introductionmentioning
confidence: 99%